Ib Acquisition Corp. IBAC

No annual revenue total was found in IB ACQUISITION CORP.'s SEC filings.

Ib Acquisition Corp. (IBAC) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research.

Revenue
—
Net income (TTM)
$-399,569
-111.1% vs year-ago TTM
Operating cash flow (TTM)
$-1.85M
-40.6% vs year-ago TTM
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
5.74M
-63.6% vs prior year
Net cash
—
Operating margin
—

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
IBAC (Nasdaq), IBACR (Nasdaq)
Fiscal year ends
September 30
Incorporated in
NV
Headquarters
Boca Raton, FL
SEC filer status
, Emerging growth company
SEC CIK
1998781

Other Services-Commercial Physical & Biological Research companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
Operating income
-$748,908
-$523,974
Net income
$3.4M
$1.9M
Operating cash flow
-$1.3M
-$820,959
Total assets
$17.1M
$119.8M
Total liabilities
$1.8M
$722,230
Stockholders' equity
-$681,323
$1.1M
Cash and investments
$428,700
$822,799

Recent SEC filings

Recent SEC filings
Form Description Filed Period
ARS Annual report to shareholders Nov 4, 2026 Sep 30, 2025
8-K Current report
Other events
Oct 15, 2026 Oct 12, 2026
8-K Current report
Listing notice
Oct 6, 2026 Oct 5, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Sep 30, 2026 Sep 24, 2026
8-K/A Amended current report
Material agreement, Unregistered share sale
Sep 23, 2026 Sep 15, 2026
8-K Current report
Material agreement
Sep 21, 2026 Sep 15, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.